Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 5, 2023
[ Thu, Oct 05th 2023
] - WOPRAI
[ Thu, Oct 05th 2023
] - WOPRAI
[ Thu, Oct 05th 2023
] - WOPRAI
[ Thu, Oct 05th 2023
] - WOPRAI
[ Thu, Oct 05th 2023
] - WOPRAI
[ Thu, Oct 05th 2023
] - WOPRAI
[ Thu, Oct 05th 2023
] - WOPRAI
[ Thu, Oct 05th 2023
] - WOPRAI
[ Thu, Oct 05th 2023
] - WOPRAI
[ Thu, Oct 05th 2023
] - WOPRAI
Wed, October 4, 2023
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
Colin Bristow Maintained (ALXO) at Strong Buy with Decreased Target to $27 on, Oct 4th, 2023
Colin Bristow of UBS, Maintained "ALX Oncology Holdings Inc." (ALXO) at Strong Buy with Decreased Target from $29 to $27 on, Oct 4th, 2023.
Colin has made no other calls on ALXO in the last 4 months.
There are 3 other peers that have a rating on ALXO. Out of the 3 peers that are also analyzing ALXO, 0 agree with Colin's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Colin
- Swayampakula Ramakanth of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $18 on, Tuesday, October 3rd, 2023
- Alethia Young of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $18 on, Tuesday, September 12th, 2023
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $8 on, Friday, August 11th, 2023
